Navigation Links
Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab

20 mg/kg, single or multiple doses) alone or in combination with dacarbazine, interleukin-2, or gp100 peptide vaccine. The primary endpoint of this analysis was to examine the kinetics of response to ipilimumab in 356 patients with stage III or stage IV metastatic melanoma; secondary endpoints included duration of objective response (defined as complete or partial response) and stable disease. Analysis of the kinetics of response data demonstrated:

    - Complete or partial response achieved in 13% (46/356) of patients.  Of

      these 46 patients:

      - 61% (28/46) achieved an objective response at week 12 or later

      - 35% (16/46) achieved stable disease prior to objective response

        (complete or partial)

      - 22% (10/46) achieved a partial response, which developed into a

        complete response

    - Current median duration of stable disease (from five of the six studies)

      was more than 15.4 weeks (median duration of objective response has not

      yet been reached).  Twenty-five patients continue to respond with the

      longest response still ongoing at five years.

As previously reported for each individual study, the most common adverse events were immune-related (irAEs) including rash and diarrhea, which were medically manageable and reversible with treatment.

"In some cases, responses were achieved at 12 weeks or later in patients whose disease progressed after treatment with ipilimumab, suggesting that continued treatment through apparent disease progression may be beneficial," said Geoffrey M. Nichol, MBChB, Senior Vice President of Product Development at Medarex. "Further research is needed to fully understand how immunotherapies differ from currently approved chemotherapies."

About Ipilimumab

Ipilimumab is a fully human antibody that binds to CTLA-4 (cytotoxic T lymphocyte-associated antigen 4), a molecule on T-cells that is believed to play a critical role in regulating natural
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
6. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
7. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
9. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
Post Your Comments:
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... Advanced Bearing Technology with Vitamin E by celebrating a ... this month reported that, at 96 million cycles of ... Technology featuring Vitamin E grafted highly crosslinked polyethylene hip ... reduction of 95 percent, with no cracking, delamination or ...
(Date:3/26/2015)... -- Even the Score today marked this week,s 17 ... landmark approval of Viagra with the release of a ... the Agency to begin restoring gender equity in sexual ... most common sexual dysfunction. Currently, men have ... dysfunction – while women have zero biological treatment options ...
(Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... July 27, 2011 Reportlinker.com announces that ... in its catalogue: India ... Till 2016 http://www.reportlinker.com/p0575381/India-Cardiac-Catheters-and-Guidewires---Market-Trends-Till-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... This market report provides vital ...
... 26, 2011 Symmetry Medical Inc. (NYSE: SMA ... orthopaedic device industry and other medical markets, announced today that ... period ending July 2, 2011 before the market opens on ... conference call at 8:00 a.m. ET on Thursday, August 4, ...
Cached Medicine Technology:India Cardiac Catheters and Guidewires - Market Trends Till 2016 2India Cardiac Catheters and Guidewires - Market Trends Till 2016 3Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:3/27/2015)... 2015 In light of two lawsuits ... U.S. District Court, District of Massachusetts; and case number ... of Pennsylvania), the San Diego personal injury lawyers of ... announcing that they are available to investigate potential ... were prescribed Zofran while pregnant and who gave birth ...
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
(Date:3/26/2015)... 26, 2015 Xarelto lawsuits ( ... with the issuance of new court documents in ... According to an Order dated March 24th, the ... Xarelto injury claims in the U.S. District Court, ... to file cases directly in the proceeding. (In ...
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate the ... parents who are working to reduce sugar in their family ... public health, and we will continue to stand on the ... families,” said Dr. Jane Delgado President and CEO of the ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. DeLauro. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
... the illness and depression, anxiety disorders, researchers say , ... of people with Parkinson,s disease are at increased risk ... The risk is particularly high in the brothers, sisters, ... age 75, said a team from the Mayo Clinic ...
... of Native American tribes, public health and environmental ... in,the U.S. Court of Appeals for the District ... that evade legally required cuts in,mercury pollution from ... broad coalition called for the complete reversal of ...
... Los,Angeles Jewish Home today broke ground on the first ... a decade, the newest in,California and the fastest-selling CCRC ... years after the city,s first senior housing was created ... to the number of,elderly residing in the region. Fountainview ...
... MOINES, Iowa, Dec. 6 A group of physicians ... appealing to both Democratic and,Republican candidates for President to ... highest quality hospitals, including their own., The appeal ... that was,prompted by threatened action by Senator Max Baucus, ...
... of Frutels, the Vitamin ... Gummy for Acne, ... principal of new business development consultancy BANKS., has,agreed to join Frutels, LLC ... years of executive marketing experience in apparel,cosmetics, fragrance and fashion accessories to ...
... to enhance care for Philadelphia Latinos, PHILADELPHIA, Dec. ... providing a total of $925,000 in funding through 2010,to ... of its,Charitable Medical Care Grant Program. The Grant program, ... that provide,free or low-cost health care to more than ...
Cached Medicine News:Health News:Relatives of Parkinson's Patients at Higher Psychiatric Risk 2Health News:EPA Plan to Evade Required Cuts in Mercury Pollution Challenged in Court by States, Tribes, Health and Environmental Groups 2Health News:Construction Begins on Los Angeles' First New Continuing Care Retirement Community Facility in Over a Decade 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 3Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 4Health News:Marketing Powerhouse Wendy Banks Joins Frutels' Advisory Board 2Health News:Independence Blue Cross Gives Grants to Support Health Care for the Uninsured 2
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Controls...
Pefakit PiCT LMWH Calibrators...
Pefakit TAFI Calibrators and Controls...
Medicine Products: